Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It is indicated for the treatment of gastro‑oesophageal reflux disease (GERD), erosive oesophagitis, prevention of NSAID‑induced gastric ulcers, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Nexium (esomeprazole) is a proton pump inhibitor used to reduce gastric acid production in several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): reduces acid reflux symptoms and promotes healing of esophageal irritation. - Erosive oesophagitis: facilitates ulcer healing and prevents further mucosal damage. - NSAID‑induced gastric ulcer prevention: protects the gastric lining in patients receiving non‑steroidal anti‑inflammatory drugs. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Esomeprazole may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often reported during therapy. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Anaphylaxis: life‑threatening allergic reaction with rash, swelling, and respiratory distress. - Serum magnesium decrease: low magnesium levels that may cause muscle weakness or cardiac arrhythmia.

Before initiating esomeprazole therapy, several precautionary measures should be considered.

- Assess renal function: dose adjustment may be required in severe renal impairment. - Monitor magnesium levels: prolonged use can lead to hypomagnesemia. - Caution in hepatic impairment: patients with liver disease may have altered drug metabolism. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use with caution during pregnancy: safety data are limited; evaluate risk‑benefit. - Store at room temperature: keep in the original container, protect from light and moisture.

Esomeprazole can affect the pharmacokinetics of several concomitant medicines, requiring attention to potential interactions.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to subtherapeutic antiviral levels. - Rilpivirine: lowered exposure, compromising HIV treatment efficacy.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations, risk of toxicity. - Warfarin: enhanced anticoagulant effect, may require INR monitoring. - Iron salts: reduced iron absorption, consider separate dosing times.